ATE97570T1 - Arzneimittel zur verhuetung von sexuell uebertragbaren krankheiten. - Google Patents

Arzneimittel zur verhuetung von sexuell uebertragbaren krankheiten.

Info

Publication number
ATE97570T1
ATE97570T1 AT89401979T AT89401979T ATE97570T1 AT E97570 T1 ATE97570 T1 AT E97570T1 AT 89401979 T AT89401979 T AT 89401979T AT 89401979 T AT89401979 T AT 89401979T AT E97570 T1 ATE97570 T1 AT E97570T1
Authority
AT
Austria
Prior art keywords
medications
prevention
sexually transmitted
transmitted diseases
diseases
Prior art date
Application number
AT89401979T
Other languages
English (en)
Inventor
Jacques Julien Augros
Original Assignee
Sspl Sa Safe Sex Prod Licens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sspl Sa Safe Sex Prod Licens filed Critical Sspl Sa Safe Sex Prod Licens
Application granted granted Critical
Publication of ATE97570T1 publication Critical patent/ATE97570T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
AT89401979T 1988-07-11 1989-07-10 Arzneimittel zur verhuetung von sexuell uebertragbaren krankheiten. ATE97570T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8809418 1988-07-11
EP89401979A EP0351301B1 (de) 1988-07-11 1989-07-10 Arzneimittel zur Verhütung von sexuell übertragbaren Krankheiten

Publications (1)

Publication Number Publication Date
ATE97570T1 true ATE97570T1 (de) 1993-12-15

Family

ID=9368330

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89401979T ATE97570T1 (de) 1988-07-11 1989-07-10 Arzneimittel zur verhuetung von sexuell uebertragbaren krankheiten.

Country Status (38)

Country Link
US (1) US5439685A (de)
EP (1) EP0351301B1 (de)
JP (1) JPH0774164B2 (de)
KR (1) KR0143231B1 (de)
CN (1) CN1035038C (de)
AP (1) AP108A (de)
AR (1) AR243381A1 (de)
AT (1) ATE97570T1 (de)
BR (1) BR8903523A (de)
CA (1) CA1341304C (de)
CZ (1) CZ280722B6 (de)
DD (1) DD283932A5 (de)
DE (1) DE68910892T2 (de)
DK (1) DK173527B1 (de)
ES (1) ES2062065T3 (de)
FI (1) FI101595B (de)
HK (1) HK131095A (de)
HU (1) HU206634B (de)
IE (1) IE63115B1 (de)
IL (1) IL90910A (de)
LT (1) LT3754B (de)
LV (1) LV10573B (de)
MA (1) MA22036A1 (de)
MD (1) MD406C2 (de)
MX (1) MX170801B (de)
MY (1) MY106242A (de)
NO (1) NO178843C (de)
NZ (1) NZ229891A (de)
OA (1) OA09123A (de)
PL (1) PL161848B1 (de)
PT (1) PT91108B (de)
RU (1) RU2065742C1 (de)
SK (1) SK423889A3 (de)
TN (1) TNSN89074A1 (de)
TR (1) TR28353A (de)
UA (1) UA26124A (de)
YU (1) YU47899B (de)
ZA (1) ZA895263B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02258718A (ja) * 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
US5795870A (en) * 1991-12-13 1998-08-18 Trustees Of Princeton University Compositions and methods for cell transformation
US5693769A (en) * 1991-12-13 1997-12-02 Transcell Technologies, Inc. Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
IT1255450B (it) * 1992-06-30 1995-10-31 Montefarmaco Spa Uso di acidi biliari come agenti antivirali
CA2167537A1 (en) * 1993-07-19 1995-02-02 Tsuneo Ozeki Hepatitis c virus proliferation inhibitor
DE4341139C1 (de) * 1993-12-02 1995-04-13 Upmeyer Hans Juergen Dimeticon zur Behandlung von Aphthen
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
US5700679A (en) * 1996-06-07 1997-12-23 Novavax, Inc. Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
WO1998010744A1 (en) * 1996-09-12 1998-03-19 Simon Everard Barton Composition comprising an antiviral or antibacterial agent for preventing transmission of diseases
US6211243B1 (en) 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
ATE489937T1 (de) * 2000-03-07 2010-12-15 Rush Presbyterian St Luke Zusammensetzungen und deren verwendung zum abfangen und inaktivieren pathogener mikroben und spermatozoen
GB2415626B (en) * 2001-04-11 2006-03-08 Playtex Products Inc Use of a catamenial tampon which comprises a cationic surfactant for the treatment of vaginal malodor
US8093446B2 (en) * 2001-04-11 2012-01-10 Playtex Products, Inc. Fibrous absorbent articles having malodor counteractant
GB2412121B (en) * 2001-04-11 2006-01-11 Playtex Products Inc Tampon with malodour counteractant
ES2237732T3 (es) * 2003-11-03 2005-08-01 Peter-Hansen Volkmann Composicion para el cuidado vaginal.
NZ565590A (en) * 2005-08-29 2010-07-30 Sepsicure L L C Use of a protein free composition comprising cholinic acid and a phosphosphlipid for the treatment or prevention of conditions caused by gram-positive bacteria
DE102006020644A1 (de) * 2006-04-28 2007-10-31 Bayer Innovation Gmbh Antiseptikahaltige Silikonelastomere
US8409557B2 (en) 2006-09-28 2013-04-02 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US8062631B2 (en) 2006-09-28 2011-11-22 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
AU2012203566B1 (en) * 2008-03-27 2013-09-12 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
KR101130754B1 (ko) 2010-06-25 2012-03-28 제일약품주식회사 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물
US9078813B2 (en) 2010-11-12 2015-07-14 The University Of Utah Research Foundation Intravaginal devices for controlled delivery of lubricants
CN103619341A (zh) 2011-04-19 2014-03-05 Arms制药有限公司 抑制有害微生物的方法及其阻隔形成组合物
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
CA2781379C (en) 2012-03-26 2013-09-03 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
DE102020131233A1 (de) * 2020-11-25 2022-05-25 Netzsch Trockenmahltechnik Gmbh Verfahren zur herstellung eines homogenisierten gemischs aus kohlenstoff, schwefel und ptfe
KR102399883B1 (ko) * 2021-02-09 2022-05-20 재단법인대구경북과학기술원 압출용 복합고분자 펠릿 및 이의 제조방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1161484A (en) * 1965-08-20 1969-08-13 Mediline Ag Toilet Preparation
SE353658B (de) * 1967-06-13 1973-02-12 Dow Corning
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US3770648A (en) * 1971-07-12 1973-11-06 Bristol Myers Co Anhydrous aerosol foam
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US4393871A (en) * 1977-06-27 1983-07-19 Vli Corporation Vaginal device
US4228797A (en) * 1978-09-25 1980-10-21 Dickey Richard P Intravaginal contraception method
ZA827582B (en) * 1981-11-06 1983-08-31 Ansell Inc Spermicidal condom
JPS58103453A (ja) * 1981-12-07 1983-06-20 シンテツクス（ユ−・エス・エイ）インコ−ポレイテツド １−置換イミダゾ−ルを放出する使い捨て膣内避妊具
DE3204124A1 (de) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen Antimykotische tampons mit hoher wirkstoff-freisetzung
AU2272883A (en) * 1982-12-22 1984-06-28 Herpes Pharmaceutical Inc. Pharmaceutical compositions of steriods for treatment of herpes simplex infections
DE3346641A1 (de) * 1983-12-23 1985-07-04 Dynamit Nobel Ag, 5210 Troisdorf Silanmodifizierte estergemische
GB8402748D0 (en) * 1984-02-02 1984-03-07 Dunlop Ltd Intravaginal device
NL8600929A (nl) * 1986-04-11 1987-11-02 Fundatech Sa Werkwijze voor het vervaardigen van een gemedicateerd wegwerp-pessarium en gemedicateerd wegwerp-pessarium.
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
US4952411A (en) * 1987-02-25 1990-08-28 Trustees Of Columbia University In The City Of New York Method of inhibiting the transmission of AIDS virus
GB8706313D0 (en) * 1987-03-17 1987-04-23 Health Lab Service Board Treatment & prevention of viral infections
FR2614525B1 (fr) * 1987-04-29 1995-11-10 Jacques Augros Tampon en eponge elastique, notamment tampon vaginal
US4922928A (en) * 1988-08-17 1990-05-08 Michael Burnhill Vaginal device

Also Published As

Publication number Publication date
LT3754B (en) 1996-03-25
FI893340A (fi) 1990-01-12
EP0351301A2 (de) 1990-01-17
FI101595B1 (fi) 1998-07-31
FI101595B (fi) 1998-07-31
DE68910892D1 (de) 1994-01-05
YU47899B (sh) 1996-05-20
DK340289D0 (da) 1989-07-10
CN1041879A (zh) 1990-05-09
PT91108A (pt) 1990-02-08
DE68910892T2 (de) 1994-05-05
NO178843C (no) 1996-06-19
PT91108B (pt) 1995-01-31
SK278614B6 (en) 1997-11-05
IE892218L (en) 1990-01-11
HK131095A (en) 1995-08-24
PL280531A1 (en) 1990-05-28
KR900001366A (ko) 1990-02-27
PL161848B1 (pl) 1993-08-31
BR8903523A (pt) 1991-11-05
US5439685A (en) 1995-08-08
AP108A (en) 1991-02-23
CA1341304C (fr) 2001-10-09
AU625716B2 (en) 1992-07-16
AR243381A1 (es) 1993-08-31
NO892826D0 (no) 1989-07-07
MY106242A (en) 1995-04-29
CZ423889A3 (en) 1995-12-13
HU206634B (en) 1992-12-28
IL90910A (en) 1994-12-29
NZ229891A (en) 1991-01-29
OA09123A (fr) 1991-10-31
LTIP1660A (en) 1995-07-25
HUT50445A (en) 1990-02-28
ES2062065T3 (es) 1994-12-16
YU135789A (en) 1992-05-28
IL90910A0 (en) 1990-02-09
AP8900133A0 (en) 1989-10-31
LV10573B (en) 1995-08-20
MD406C2 (ro) 1996-06-30
EP0351301B1 (de) 1993-11-24
NO178843B (no) 1996-03-11
ZA895263B (en) 1991-03-27
IE63115B1 (en) 1995-03-22
FI893340A0 (fi) 1989-07-10
TR28353A (tr) 1996-05-16
UA26124A (uk) 1999-06-07
TNSN89074A1 (fr) 1991-02-04
JPH02167235A (ja) 1990-06-27
MX170801B (es) 1993-09-14
JPH0774164B2 (ja) 1995-08-09
CN1035038C (zh) 1997-06-04
DD283932A5 (de) 1990-10-31
SK423889A3 (en) 1997-11-05
AU3802689A (en) 1990-01-11
MA22036A1 (fr) 1991-10-01
RU2065742C1 (ru) 1996-08-27
DK340289A (da) 1990-01-12
LV10573A (lv) 1995-04-20
DK173527B1 (da) 2001-01-29
CZ280722B6 (cs) 1996-04-17
EP0351301A3 (en) 1990-12-19
NO892826L (no) 1990-01-12
KR0143231B1 (ko) 1998-07-15

Similar Documents

Publication Publication Date Title
ATE97570T1 (de) Arzneimittel zur verhuetung von sexuell uebertragbaren krankheiten.
DE69018647D1 (de) Arzneimittel.
DE68902572D1 (de) Maskieren des geschmacks des thymols.
DE3578620D1 (de) Arzneimittel zur aeusserlichen anwendung.
DE3688296D1 (de) Arzneimittel zur behandlung von erbrechen.
FI875326A (fi) Ljusbestraolningsanordning foer medicinal vaord av oera.
NO902003L (no) Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO885454D0 (no) Fremgangsmaate for fremstilling av triklormonosilan.
NO901554L (no) Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO894210D0 (no) Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO894649D0 (no) Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid.
NO895032D0 (no) Fremgangsmaate for fremstilling av 2-benzotiazoliner.
DE3874072D1 (de) Arzneimittel fuer die kombination piperidinoalkanol-dekongestivum.
NO890159L (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
NO901067D0 (no) Fremgangsmaate for fremstilling av tiofener.
FI894921A0 (fi) Anordning foer foertunnande av kanten vid en kartongbana eller -ark.
NO895040D0 (no) Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer.
NO900969L (no) Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
DE3877747D1 (de) Glasartige matrize zur verabreichung von heilmitteln.
NO900219D0 (no) Dihydroksybenzofenon-oksim, samt fremgangsmaate for fremstilling av slike oksimer.
DE69001540D1 (de) Arzneimittel zur rektalen verabreichung von calcitonin.
FI891544A0 (fi) Transportanordning med stoedhjul.
DE3887237D1 (de) Arzneimittel.
DE19775036I2 (de) Arzneimittel zur Behandlung von Augenentzündung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee